These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8852475)

  • 1. Treatment failure in erythema migrans--a review.
    Weber K
    Infection; 1996; 24(1):73-5. PubMed ID: 8852475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients.
    Kuiper H; Cairo I; Van Dam A; De Jongh B; Ramselaar T; Spanjaard L; Dankert J
    Br J Dermatol; 1994 Apr; 130(4):466-72. PubMed ID: 8186111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.
    Strle F; Preac-Mursic V; Cimperman J; Ruzic E; Maraspin V; Jereb M
    Infection; 1993; 21(2):83-8. PubMed ID: 8387966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions.
    Strle F; Cheng Y; Cimperman J; Maraspin V; Lotric-Furlan S; Nelson JA; Picken MM; Ruzic-Sabljic E; Picken RN
    Clin Infect Dis; 1995 Aug; 21(2):380-9. PubMed ID: 8562748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial.
    Luft BJ; Dattwyler RJ; Johnson RC; Luger SW; Bosler EM; Rahn DW; Masters EJ; Grunwaldt E; Gadgil SD
    Ann Intern Med; 1996 May; 124(9):785-91. PubMed ID: 8610947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy.
    Schmidt B; Muellegger RR; Stockenhuber C; Soyer HP; Hoedl S; Luger A; Kerl H
    J Clin Microbiol; 1996 Jun; 34(6):1359-63. PubMed ID: 8735081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.
    Strle F; Maraspin V; Lotric-Furlan S; Ruzić-Sabljić E; Cimperman J
    Infection; 1996; 24(1):64-8. PubMed ID: 8852473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
    Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
    Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary erythema migrans in Georgia and South Carolina.
    Felz MW; Chandler FW; Oliver JH; Rahn DW; Schriefer ME
    Arch Dermatol; 1999 Nov; 135(11):1317-26. PubMed ID: 10566829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyme disease.
    Berger BW
    Semin Dermatol; 1993 Dec; 12(4):357-62. PubMed ID: 8312152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary erythema migrans in central Wisconsin.
    Melski JW; Reed KD; Mitchell PD; Barth GD
    Arch Dermatol; 1993 Jun; 129(6):709-16. PubMed ID: 8389536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
    Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
    J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.
    Berger BW; Johnson RC
    J Am Acad Dermatol; 1989 Dec; 21(6):1188-91. PubMed ID: 2511231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy indications in positive Borrelia titer].
    Graninger W
    Internist (Berl); 1999 Feb; 40(2):216. PubMed ID: 10097982
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
    Breier F; Kunz G; Klade H; Stanek G; Aberer E
    Infection; 1996; 24(1):69-72. PubMed ID: 8852474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans.
    Arnez M; Ruzić-Sabljić E; Ahcan J; Radsel-Medvescek A; Pleterski-Rigler D; Strle F
    Pediatr Infect Dis J; 2001 Mar; 20(3):251-5. PubMed ID: 11303825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review.
    Benedix F; Weide B; Broekaert S; Metzler G; Frick JS; Burgdorf WH; Röcken M; Schaller M
    Acta Derm Venereol; 2007; 87(5):418-21. PubMed ID: 17721649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.